FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in The Netherlands

Biotech startups that raised Series A in The Netherlands

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in The Netherlands
One-time CSV
  • 31 funded companies, 20 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~the-netherlands.csv31 rows × 18 columns
CompanyCityLast roundAmountDate
Matisse PharmaceuticalsGeleenSeries A$16.0M2026-09-17
KynexisNaardenSeries A$112.3M2026-08-19
QoriumMaastrichtSeries A$25.5M2025-11-11
VSPARTICLEDelftSeries A$7.1M2024-08-08
MindAffectNijmegenSeries A$1.2M2024-04-29
Flindr TherapeuticsAmsterdamSeries A$21.4M2024-04-24
VectorYAmsterdamSeries A$138.0M2023-11-13
Synerkine PharmaUtrechtSeries A$5.6M2023-10-12

8 rows of the CSV in 5 of its 18 columns.

31
Startups
$807.3M
Total raised
4
Funded in the last 12 months
$198.6M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

7 of 31
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Matisse Pharmaceuticals Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. Biotech Geleen Series A $16.0M 2026-09-17 $22.0M Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) 11 to 50 2014
Kynexis Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. Biotech Naarden Series A $112.3M 2026-08-19 $173.3M Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures 11 to 50 2023
Qorium Qorium makes reinvented real leather materials. Biotech Maastricht Series A $25.5M 2025-11-11 $28.6M Sofinnova Partners, Brightlands Venture Partners 11 to 50 2021
VSPARTICLE VSPARTICLE makes nanoparticle generators for sensors, batteries, catalysis, solar cells, and other uses. Biotech Delft Series A $7.1M 2024-08-08 BlueYard Capital, MIT delta v, NordicNinja VC +2 11 to 50 2014
MindAffect MindAffect develops brain-computer interfaces for medical applications. Artificial intelligence Nijmegen Series A $1.2M 2024-04-29 NLC, Wasteland Investments, Barco Limpo 1 to 10 2017
VectorY VectorY develops gene therapies for central nervous system, somatic, and muscle diseases. Biotech Amsterdam Series A $138.0M 2023-11-13 $175.6M Insight Partners, Benhamou Global Ventures, Forbion Capital Partners +2 51 to 100 2020
Synerkine Pharma Synerkine Pharma develops fusion proteins for treating chronic pain. Biotech Utrecht Series A $5.6M 2023-10-12 InnovationQuarter, Thuja Capital, Flerie Invest +1 1 to 10 2009

Table 1. Biotech startups that raised Series A in The Netherlands: the 7 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 31.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Kynexis Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. Biotech Naarden Series A $112.3M 2026-08-19 $173.3M Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures 11 to 50 2023
2 Matisse Pharmaceuticals Matisse Pharmaceuticals develops therapies for sepsis and septic shock by targeting cytotoxic histones. Biotech Geleen Series A $16.0M 2026-09-17 $22.0M Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF) 11 to 50 2014

Table 2. Biotech startups that raised Series A in The Netherlands: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Brightlands Venture Partners Venture capital firm Geleen, The Netherlands 2 6% 1 Matisse Pharmaceuticals
2 Forbion Capital Partners Private equity firm Naarden, The Netherlands 2 6% 1 Kynexis
3 Limburg Business Development Fund (LBDF) Corporate venture arm Maastricht, The Netherlands 1 3% 1 Matisse Pharmaceuticals
4 Chemelot Ventures Micro VC fund Urmond, The Netherlands 1 3% 1 Matisse Pharmaceuticals
5 Sunstone Life Science Ventures Micro VC fund Copenhagen, Denmark 1 3% 1 Kynexis
6 Ysios Capital Venture capital firm San Sebastian, Spain 1 3% 1 Kynexis
7 Sofinnova Partners Venture capital firm Paris, France 1 3%
8 Plural Platform Venture capital firm London, United Kingdom 1 3%
9 BlueYard Capital Venture capital firm Berlin, Germany 1 3%
10 Hermann Hauser Investment Venture capital firm Innsbruck, Austria 1 3%
11 NordicNinja VC Venture capital firm London, United Kingdom 1 3%
12 MIT delta v Startup accelerator Cambridge, United States 1 3%
13 Wasteland Investments Venture capital firm 1 3%
14 Barco Limpo 1 3%
15 NLC Startup accelerator Amsterdam, The Netherlands 1 3%

Table 3. Biotech startups that raised Series A in The Netherlands: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 24 77% $711.7M
Software 3 10%
Hardware 2 6%
Energy 1 3%
Artificial intelligence 1 3%

Table 4. Biotech startups that raised Series A in The Netherlands by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 31 100% $8.1M

Table 5. Biotech startups that raised Series A in The Netherlands by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Utrecht 4 13%
Maastricht 4 13%
Amsterdam 4 13%
Leiden 3 10%
Nijmegen 2 6%
The Hague 2 6%
Geleen 1 3%
Naarden 1 3%
Delft 1 3%
Rotterdam 1 3%
Eindhoven 1 3%
Bilthoven 1 3%

Table 6. Biotech startups that raised Series A in The Netherlands by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 25% $44.9M
September 2026 1 25% $16.0M
August 2026 1 25% $112.3M
December 2025 1 25% $25.3M

Table 7. Biotech startups that raised Series A in The Netherlands: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 3 10% $173.3M
2025 3 10% $117.8M
2024 3 10% $29.7M
2023 4 13% $214.4M
2022 2 6% $39.1M
2021 1 3% $17.3M

Table 8. Biotech startups that raised Series A in The Netherlands by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 2 6%
2020 to 2022 5 16%
2015 to 2019 11 35%
2010 to 2014 9 29%
Before 2010 4 13%

Table 9. Biotech startups that raised Series A in The Netherlands by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 8 28%
11 to 50 19 66%
51 to 100 2 7%

Table 10. Biotech startups that raised Series A in The Netherlands by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in The Netherlands whose last round is Series A are on the list?
31, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 31 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in The Netherlands: 31 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in The Netherlands

Other sectors that raised Series A in The Netherlands

Cite: FundingWatcher, 31 biotech companies in The Netherlands whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/the-netherlands/